insights_auto
Nega BOT tushdi 11,11%?
Batafsil oʻrganishchevron_right
BOT:ASX
Botanix Pharmaceuticals Ltd
0,0080 A$
arrow_downward
-11,11%(-0,00100) 1K
16-noy, 16:10:15 (GMT+11) · AUD
search
Barcha belgilar
| Belgi | Narxi | Oʻzgartirishlar | Dinamika (%) |
|---|
insights_autoBOT tikeri uchun statistika yaratilmoqda...
Ochish
0,01 A$
Yuqori
0,01 A$
Past
0,01 A$
Bozor kapitali
19,89 mln
Oʻrtacha hajm
9,99 mln
Hajmi
30,19 mln
52 haftalik eng yuqori
0,15 A$
52 haftalik eng past
0,01 A$
Aksiya boʻyicha daromad
-0,03 A$
Muomaladagi aksiyalar
2,76 mlrd
Xodimlar soni
11
Ochish
0,01 A$
Yuqori
0,01 A$
Past
0,01 A$
Bozor kapitali
19,89 mln
Oʻrtacha hajm
9,99 mln
Hajmi
30,19 mln
52 haftalik eng yuqori
0,15 A$
52 haftalik eng past
0,01 A$
Aksiya boʻyicha daromad
-0,03 A$
Muomaladagi aksiyalar
2,76 mlrd
Xodimlar soni
11
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
ChartMill
·
37 daqiqa oldin
Today's S&P 500 Top Movers: Tyson Foods Leads Gainers, Lumentum Leads Decliners
marketscreener.com
·
43 daqiqa oldin
Nasdaq, S&P 500 fall over 1% in run-up to Nvidia results, Anthropic debut
Stocktwits
·
44 daqiqa oldin
Morgan Stanley’s Mike Wilson Is Bullish On S&P 500 With A 15% Upside View For 2027
Traders Union
·
2 soat oldin
Peter Tuchman: S&P 500 loses over $800 billion in market cap
Profil
Botanix Pharmaceuticals is listed on the Australian Securities Exchange with the issue code BOT. The Company is headquartered in Perth, Western Australia and Philadelphia, USA. It is a clinical stage synthetic cannabinoid company, focusing on the compound Cannabidiol. The company's lead product is Sofdra, which treats axillary hyperhidrosis. The company has two separate development platforms, dermatology and antimicrobial. Botanix also has an exclusive license to use a proprietary drug delivery system Permetrex, for direct skin delivery of active pharmaceuticals which is utilised in all of their programs. Wikipedia
Botanix Pharmaceuticals Ltd haqida